Literature DB >> 19297571

Racial differences in incident heart failure among young adults.

Kirsten Bibbins-Domingo1, Mark J Pletcher, Feng Lin, Eric Vittinghoff, Julius M Gardin, Alexander Arynchyn, Cora E Lewis, O Dale Williams, Stephen B Hulley.   

Abstract

BACKGROUND: The antecedents and epidemiology of heart failure in young adults are poorly understood.
METHODS: We prospectively assessed the incidence of heart failure over a 20-year period among 5115 blacks and whites of both sexes who were 18 to 30 years of age at baseline. Using Cox models, we examined predictors of hospitalization or death from heart failure.
RESULTS: Over the course of 20 years, heart failure developed in 27 participants (mean [+/-SD] age at onset, 39+/-6 years), all but 1 of whom were black. The cumulative incidence of heart failure before the age of 50 years was 1.1% (95% confidence interval [CI], 0.6 to 1.7) in black women, 0.9% (95% CI, 0.5 to 1.4) in black men, 0.08% (95% CI, 0.0 to 0.5) in white women, and 0% (95% CI, 0 to 0.4) in white men (P=0.001 for the comparison of black participants and white participants). Among blacks, independent predictors at 18 to 30 years of age of heart failure occurring 15 years, on average, later included higher diastolic blood pressure (hazard ratio per 10.0 mm Hg, 2.1; 95% CI, 1.4 to 3.1), higher body-mass index (the weight in kilograms divided by the square of the height in meters) (hazard ratio per 5.7 units, 1.4; 95% CI, 1.0 to 1.9), lower high-density lipoprotein cholesterol (hazard ratio per 13.3 mg per deciliter [0.34 mmol per liter], 0.6; 95% CI, 0.4 to 1.0), and kidney disease (hazard ratio, 19.8; 95% CI, 4.5 to 87.2). Three quarters of those in whom heart failure subsequently developed had hypertension by the time they were 40 years of age. Depressed systolic function, as assessed on a study echocardiogram when the participants were 23 to 35 years of age, was independently associated with the development of heart failure 10 years, on average, later (hazard ratio for abnormal systolic function, 36.9; 95% CI, 6.9 to 198.3; hazard ratio for borderline systolic function, 3.5; 95% CI, 1.2 to 10.2). Myocardial infarction, drug use, and alcohol use were not associated with the risk of heart failure.
CONCLUSIONS: Incident heart failure before 50 years of age is substantially more common among blacks than among whites. Hypertension, obesity, and systolic dysfunction that are present before a person is 35 years of age are important antecedents that may be targets for the prevention of heart failure. (ClinicalTrials.gov number, NCT00005130.) 2009 Massachusetts Medical Society

Entities:  

Mesh:

Year:  2009        PMID: 19297571      PMCID: PMC2829671          DOI: 10.1056/NEJMoa0807265

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  42 in total

Review 1.  Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths.

Authors:  Allan D Struthers; Andrew D Morris
Journal:  Lancet       Date:  2002-04-20       Impact factor: 79.321

2.  Racial/ethnic disparities in prevalence, treatment, and control of hypertension--United States, 1999-2002.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-01-14       Impact factor: 17.586

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  Renal function and heart failure risk in older black and white individuals: the Health, Aging, and Body Composition Study.

Authors:  Kirsten Bibbins-Domingo; Glenn M Chertow; Linda F Fried; Michelle C Odden; Anne B Newman; Stephen B Kritchevsky; Tamara B Harris; Suzanne Satterfield; Steven R Cummings; Michael G Shlipak
Journal:  Arch Intern Med       Date:  2006-07-10

5.  Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis.

Authors:  Hossein Bahrami; Richard Kronmal; David A Bluemke; Jean Olson; Steven Shea; Kiang Liu; Gregory L Burke; João A C Lima
Journal:  Arch Intern Med       Date:  2008-10-27

Review 6.  The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening.

Authors:  Thomas J Wang; Daniel Levy; Emelia J Benjamin; Ramachandran S Vasan
Journal:  Ann Intern Med       Date:  2003-06-03       Impact factor: 25.391

7.  Factors associated with hypertension awareness, treatment, and control in Dallas County, Texas.

Authors:  Ronald G Victor; David Leonard; Paul Hess; Deepa G Bhat; Jennifer Jones; Patrice A C Vaeth; Joseph Ravenell; Anne Freeman; Ruth P Wilson; Robert W Haley
Journal:  Arch Intern Med       Date:  2008-06-23

8.  Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight.

Authors:  G de Simone; S R Daniels; R B Devereux; R A Meyer; M J Roman; O de Divitiis; M H Alderman
Journal:  J Am Coll Cardiol       Date:  1992-11-01       Impact factor: 24.094

9.  The epidemiology of heart failure: the Framingham Study.

Authors:  K K Ho; J L Pinsky; W B Kannel; D Levy
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

10.  The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study.

Authors:  M S Lauer; K M Anderson; W B Kannel; D Levy
Journal:  JAMA       Date:  1991-07-10       Impact factor: 56.272

View more
  224 in total

1.  Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons.

Authors:  Andy I Choi; Eric Vittinghoff; Steven G Deeks; Cristin C Weekley; Yongmei Li; Michael G Shlipak
Journal:  AIDS       Date:  2011-06-19       Impact factor: 4.177

2.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

Review 3.  Noninvasive measurement of central vascular pressures with arterial tonometry: clinical revival of the pulse pressure waveform?

Authors:  Matthew R Nelson; Jan Stepanek; Michael Cevette; Michael Covalciuc; R Todd Hurst; A Jamil Tajik
Journal:  Mayo Clin Proc       Date:  2010-05       Impact factor: 7.616

4.  Isosorbide dinitrate and hydralazine as therapy for African Americans with heart failure; a failed paradigm?

Authors:  Clyde W Yancy; Arthur Feldman
Journal:  Clin Transl Sci       Date:  2009-08       Impact factor: 4.689

5.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-12-15       Impact factor: 29.690

6.  Endogenous nitric oxide formation correlates negatively with circulating matrix metalloproteinase (MMP)-2 and MMP-9 levels in black subjects.

Authors:  Ingrid F Metzger; Valéria C Sandrim; Jose E Tanus-Santos
Journal:  Mol Cell Biochem       Date:  2011-09-29       Impact factor: 3.396

7.  N-terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: Multi-Ethnic Study of Atherosclerosis.

Authors:  Eui-Young Choi; Hossein Bahrami; Colin O Wu; Philip Greenland; Mary Cushman; Lori B Daniels; Andre L C Almeida; Kihei Yoneyama; Anders Opdahl; Aditya Jain; Michael H Criqui; David Siscovick; Christine Darwin; Alan Maisel; David A Bluemke; Joao A C Lima
Journal:  Circ Heart Fail       Date:  2012-10-02       Impact factor: 8.790

8.  Short-term trends in heart failure-related hospitalizations in a high-risk state.

Authors:  Uchechukwu K A Sampson; Baqar A Husaini; Van A Cain; Zahid Samad; Eiman C Jahangir; Robert S Levine
Journal:  South Med J       Date:  2013-02       Impact factor: 0.954

9.  Associations of cardiac structure with obesity, blood pressure, inflammation, and insulin resistance in African-American adolescents.

Authors:  Samuel S Gidding; Robert A Palermo; Stephanie S DeLoach; Scott W Keith; Bonita Falkner
Journal:  Pediatr Cardiol       Date:  2013-10-06       Impact factor: 1.655

10.  Characteristics and outcomes of patients with advanced chronic systolic heart failure receiving care at the Veterans Affairs versus other hospitals: insights from the Beta-blocker Evaluation of Survival Trial (BEST).

Authors:  Linda G Jones; Mo-Kyung Sin; Fadi G Hage; Raya E Kheirbek; Charity J Morgan; Michael R Zile; Wen-Chih Wu; Prakash Deedwania; Gregg C Fonarow; Wilbert S Aronow; Sumanth D Prabhu; Ross D Fletcher; Ali Ahmed; Richard M Allman
Journal:  Circ Heart Fail       Date:  2014-12-05       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.